This week the CME and New York Portfolio Clearing (NYPC) both made announcements related to how they’ll help clients by allowing them to cross margin various interest rate related products. Bloomberg News does a good job of explaining the whole thing here. TABB’s research director and I debate the merits of both proposals and try to figure out who will win and if this all makes the world a riskier place.